| |
|
|
|
Calithera Biosciences Inc.  
|
|
4.86 -0.04 (-0.01%) |
12-10 16:00 |
|
Open: |
4.88 |
Pre close: |
4.9 |
Target:
|
5.90 
|
|
High: |
5.1 |
Low: |
4.81 |
Resistance:
|
5.05
5.63
|
|
Volume: |
197,265 |
Market Cap: |
185M |
Support:
|
4.11
3.42
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.99
|
MACD |
MACD(12,26):
|
-0.04 |
|
MA(20): |
4.92 |
Signal(12,26,9): |
-0.05  |
|
MA(100): |
4.95 |
Stochastic Oscillator |
%K(14,3):
|
36.84 |
|
MA(250): |
6.00 |
%D(3): |
45.22 |
|
Average Volume(K) |
3-Month: |
36223
|
52-Week |
High:
|
9.35 |
|
10-Days: |
27355 |
Low: |
4.05 |
|
RSI |
RSI(14):
|
46.96 |
Change(%): |
-44.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.290 |
Return on Equity (ttm) |
-31.4 |
Shares Out. (M) |
38.13 |
|
EPS Est. Current Year |
-0.810 |
Return on Assets (ttm) |
-26.1 |
Shares Float (M) |
37.92 |
|
EPS Est. Next Year |
-1.050 |
PEG Ratio |
-0.05 |
% Held by Insiders |
0.60 |
|
EPS Est. Next Quarter |
-0.230 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
98.40 |
|
Forward EPS |
-1.879 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
1.390 |
EBITDA (p.s.) |
0.000 |
P/E |
-3.77 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.50 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-62.32 |
P/S |
225990000.00 |
|
Operating Margin |
-164.70 |
Levered Free Cash Flow
(M) |
-47.17 |
P/CF |
-2.97 |
|
|
|
|
|
|
